MBX Biosciences, Inc. Common Stock
USD53.85
+1.54 (+2.94%)
CEO
Peter Kent Hawryluk
IPO Date
2000-01-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$52.63
Prev. Close
$52.31
Day Low
$52.63
Day High
$55.00
52W Low
$9.63
52W High
$55.00
Market Cap
$1.81B
Volume
1.05M
| 12,500 |
| $30.91 |
| 5 Jun 2026 | Heron Patrick J | director, 10 percent owner: | A-Award | Acquired | 12,500 | $30.91 |
| 5 Jun 2026 | Stelzer Laurie | director | A-Award | Acquired | 12,500 | $30.91 |
| 5 Jun 2026 | Hoerter Steven L. | director | A-Award | Acquired | 12,500 | $30.91 |
| 5 Jun 2026 | Ryder Steven | director | A-Award | Acquired | 12,500 | $30.91 |
| 5 Jun 2026 | Aynechi Tiba | director | A-Award | Acquired | 12,500 | $30.91 |
| 11 May 2026 | Azoulay Salomon | Chief Medical Officer | M-Exempt | Acquired | 55,000 | $10.46 |
| 11 May 2026 | Azoulay Salomon | Chief Medical Officer | S-Sale | Disposed | 55,000 | $38.38 |
| 11 May 2026 | Azoulay Salomon | Chief Medical Officer | M-Exempt | Acquired | 15,003 | $16.00 |